The Gendered Nature of Ecosystem Services

This is the final version. Available from Elsevier via the DOI in this record. This article assesses the extent to which our conceptualisation, understanding and empirical analysis of ecosystem services are inherently gendered; in other words, how they might be biased and unbalanced in terms of their appreciation of gender differences. We do this by empirically investigating how women and men are able to benefit from ecosystem services across eight communities in coastal Kenya and Mozambique. Our results highlight different dimensions of wellbeing affected by ecosystem services, and how these are valued differently by men and women. However, it is not just the division of costs and benefits of ecosystem services that is gendered. Using a heuristic device of the ‘ecosystem-wellbeing chain’ we explain patterns within our primary data as an outcome of gendered knowledge systems, gendered behavioural expectations, gendered access to resources and gendered institutions. We conclude that this holistic, gendered understanding of ecosystem services is important not just for how ecosystem services are conceptualised, but also for the development and implementation of sustainable and equitable policy and interventions.Natural Environment Research Council (NERC)Ecosystem Services for Poverty Alleviation (ESPA)Economic and Social Research Council (ESRC

Going beyond carbon: An "Earth system impact" score to better capture corporate and investment impacts on the earth system

Corporations are responsible for a significant portion of observed impacts on the Earth system, including green-house gas (GHG) emissions, but also water extraction, landuse change and other pressures on nature. These nature-related impacts are essential to consider and capture because they have local impacts on a range of ecosystem functions on which companies and economies depend, but they also fundamentally affect our ability to mitigate and adapt to a changing climate. Furthermore, climate, land and water interact and affect each other in various ways, such that climate change can be exacerbated by degraded ecosystems, which in turn are dependent on water. This paper tests a novel metric developed to capture corporate Earth system impact (ESI) beyond merely direct GHG emissions and explores how such a tool could be used to improve assessments of corporate environmental impacts and support decisions on where to direct public and private investments. We use the mining sector as a test case to illustrate the applicability of the ESI score and examine the impact of the the five largest (by market cap) mining companies in the precious metal mining sector and the top five in the non-precious metal mining sector. We find that many of the mining assets have non-negligible impacts on land and water, and we show that the ESI metric identifies a different set of asset for targeted action than conventional carbon intensity scores would do

Unlocking the unsustainable rice-wheat system of Indian Punjab : assessing alternatives to crop-residue burning from a systems perspective

This work was funded by Formas (Project # 2018-01824), and through the generous support of the Erling-Persson Family Foundation to the Global Economic Dynamics and the Biosphere, the Royal Swedish Academy of Sciences, Sweden.Crop residue burning in Indian Punjab emits particulate matter with detrimental impacts on health, climate and that threaten agricultural production. Though legal and technological barriers to residue burning exist – and alternatives considered more profitable to farmers – residue burning continues. We review black carbon (BC) emissions from residue burning in Punjab, analyse social-ecological processes driving residue burning, and rice and wheat value-chains. Our aims are to a) understand system feedbacks driving agricultural practices in Punjab; b) identify systemic effects of alternatives to residue burning and c) identify companies and financial actors investing in agricultural production in Punjab. We find feedbacks locking the system into crop residue burning. The Government of India has greatest financial leverage and risk in the current system. Corporate stakeholders have little financial incentive to enact change, but sufficient stakes in the value chains to influence change. Agricultural policy changes are necessary to reduce harmful impacts of current practices, but insufficient to bringing about sustainability. Transformative changes will require crop diversification, circular business models and green financing. Intermediating financial institutions setting sustainability conditions on loans could leverage these changes. Sustainability requires the systems perspective we provide, to reconnect production with demand and with supporting environmental conditions.Publisher PDFPeer reviewe

Elasticity in ecosystem services: Exploring the variable relationship between ecosystems and human well-being

Although ecosystem services are increasingly recognized as benefits people obtain from nature, we still have a poor understanding of how they actually enhance multidimensional human well-being, and how well-being is affected by ecosystem change. We develop a concept of “ecosystem service elasticity” (ES elasticity) that describes the sensitivity of human well-being to changes in ecosystems. ES Elasticity is a result of complex social and ecological dynamics and is context dependent, individually variable, and likely to demonstrate nonlinear dynamics such as thresholds and hysteresis. We present a conceptual framework that unpacks the chain of causality from ecosystem stocks through flows, goods, value, and shares to contribute to the well-being of different people. This framework builds on previous conceptualizations, but places multidimensional well-being of different people as the final element. This ultimately disaggregated approach emphasizes how different people access benefits and how benefits match their needs or aspirations. Applying this framework to case studies of individual coastal ecosystem services in East Africa illustrates a wide range of social and ecological factors that can affect ES elasticity. For example, food web and habitat dynamics affect the sensitivity of different fisheries ecosystem services to ecological change. Meanwhile high cultural significance, or lack of alternatives enhance ES elasticity, while social mechanisms that prevent access can reduce elasticity. Mapping out how chains are interlinked illustrates how different types of value and the well-being of different people are linked to each other and to common ecological stocks. We suggest that examining chains for individual ecosystem services can suggest potential interventions aimed at poverty alleviation and sustainable ecosystems while mapping out of interlinkages between chains can help to identify possible ecosystem service trade-offs and winners and losers. We discuss conceptual and practical challenges of applying such a framework and conclude on its utility as a heuristic for structuring interdisciplinary analysis of ecosystem services and human wellbeing.This paper results from the project Sustainable Poverty Alleviation from Coastal Ecosystem Services (SPACES) project number NE-K010484-1, funded by the Ecosystem Services for Poverty Alleviation (ESPA) programme. The ESPA programme is funded by the Department for International Development (DFID), the Economic and Social Research Council (ESRC), and the Natural Environment Research Council (NERC).

The Gendered Nature of Ecosystem Services

This article assesses the extent to which our conceptualisation, understanding and empirical analysis of ecosystem services are inherently gendered; in other words, how they might be biased and unbalanced in terms of their appreciation of gender differences. We do this by empirically investigating how women and men are able to benefit from ecosystem services across eight communities in coastal Kenya and Mozambique. Our results highlight different dimensions of wellbeing affected by ecosystem services, and how these are valued differently by men and women. However, it is not just the division of costs and benefits of ecosystem services that is gendered. Using a heuristic device of the ‘ecosystem-wellbeing chain’, we explain patterns within our primary data as an outcome of gendered knowledge systems, gendered behavioural expectations, gendered access to resources and gendered institutions. We conclude that this holistic, gendered understanding of ecosystem services is important not just for how ecosystem services are conceptualised, but also for the development and implementation of sustainable and equitable policy and interventions

Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia

Background: Tyrosine kinase inhibitors (TKIs) are the front-line therapy for chronic myeloid leukemia (CML), where phase 3 clinical trials have demonstrated their safety and efficacy. However, trial patients may not be representative of real-world patients (RWPs). Objective: To evaluate RWP clinical factors associated with effectiveness and safety in CML patients treated with TKIs. Methods: Patients with CML treated with at least 30 days of imatinib, dasatinib, nilotinib, or bosutinib between 2014 and 2018 were included. Patients were stratified into categories based on the number of factors that would have precluded enrollment into pivotal TKI phase 3 trials (0, 1, ≥2). End points included complete hematologic response (CHR), early molecular response (EMR), major molecular response (MMR), adverse event (AE)-induced dose decreases, treatment interruptions, and treatment discontinuations. Results: Final analyses included 174 patients. Patients with ≥2 factors had a higher risk of dose decreases (relative risk = 1.54; 95% CI = 1.02-2.34; P = 0.02) and a shorter time to dose decrease (hazard ratio = 2.43; 95% CI = 1.23-4.97; P = 0.006) compared with patients with 0 factors. Significant differences were observed in CHR at 1 month and MMR at 3 months between patients with 0 and ≥2 factors (P = 0.03 and P = 0.04, respectively). Conclusion and Relevance: Approximately 60% of our RWPs would have been excluded from the pivotal phase 3 TKI trials. These data suggest that RWPs require more precise dosing to achieve CML clinical milestones and to mitigate AEs, but findings should be validated prospectively

A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer

Introduction Radium-223, abiraterone, and enzalutamide have each been shown to significantly improve survival as monotherapy in patients with metastatic castration-resistant prostate cancer. However, effects of combination radium-223 plus abiraterone or enzalutamide on survival and safety remain unclear. Patients and methods This single-center retrospective cohort study used electronic health record data of patients with metastatic castration-resistant prostate cancer and bone metastases who were treated with radium-223 between April 1, 2014 and February 19, 2019. Patients who received radium-223 monotherapy were compared to patients who received a combination of radium-223 plus either abiraterone or enzalutamide. The primary endpoint was overall survival. Secondary endpoints included progression-free survival, time to symptomatic skeletal event, symptomatic skeletal event-free survival, and incidence of drug-related adverse events. Time-to-event analyses were estimated by log rank tests using Kaplan-Meier curves. Hazard ratios and 95% confidence intervals were derived from Cox proportional hazards models. Chi-square tests evaluated difference in serious adverse events between the two arms. Results A total of 60 patients met inclusion criteria (n = 41 in the monotherapy arm, n = 19 in the combination arm). Differences in median overall survival were not observed (12.7 vs. 12.8 months; HR 1.15, 95% CI 0.59-2.23; P = 0.68), but median progression-free survival was significantly longer in the combination arm (7.6 vs. 4.9 months; HR 1.94, 95% CI 1.11-3.40; P = 0.02). Significant differences were not observed in time to first SSE (P = 0.97), SSE-free survival (P = 0.16), or in the overall incidence of serious adverse events (P = 0.45). Conclusion Combination radium-223 plus abiraterone or enzalutamide did not improve overall survival, but prolonged progression-free survival without increasing the incidence of serious adverse events in metastatic castration-resistant prostate cancer patients with bone metastases. However, these results are limited by small numbers and patient selection inherent in retrospective analysis

Food in the Anthropocene: the EAT-Lancet Commission on healthy diets from sustainable food systems

PRIFPRI3; ISI; 2 Promoting Healthy Diets and Nutrition for all; 1 Fostering Climate-Resilient and Sustainable Food Supply; UNFSSDG

Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing

PURPOSE: A number of institutions have clinically implemented CYP2D6 genotyping to guide drug prescribing. We compared implementation strategies of early adopters of CYP2D6 testing, barriers faced by both early adopters and institutions in the process of implementing CYP2D6 testing, and approaches taken to overcome these barriers. METHODS: We surveyed eight early adopters of CYP2D6 genotyping and eight institutions in the process of adoption. Data were collected on testing approaches, return of results procedures, applications of genotype results, challenges faced, and lessons learned. RESULTS: Among early adopters, CYP2D6 testing was most commonly ordered to assist with opioid and antidepressant prescribing. Key differences among programs included test ordering and genotyping approaches, result reporting, and clinical decision support. However, all sites tested for copy-number variation and nine common variants, and reported results in the medical record. Most sites provided automatic consultation and had designated personnel to assist with genotype-informed therapy recommendations. Primary challenges were related to stakeholder support, CYP2D6 gene complexity, phenotype assignment, and sustainability. CONCLUSION: There are specific challenges unique to CYP2D6 testing given the complexity of the gene and its relevance to multiple medications. Consensus lessons learned may guide those interested in pursuing similar clinical pharmacogenetic programs